Areas of Focus

Cardiomyopathies and heart failure are prevalent life-threatening cardiac conditions caused by impaired myocardial function, serving as key therapeutic targets for cardiac-targeted siRNA delivery. Youngen is exploring RNAi-based approaches to develop a targeted therapeutic solution for these serious cardiac conditions.

Leveraging mature hepatic targeting strategies and optimized oligonucleotide modification systems, Youngen’s liver-targeted delivery pipeline enables efficient, stable, and high-specificity accumulation of RNAi therapeutics. These platform capabilities support the development of advanced biotech solutions and innovative therapeutic solutions for cardiovascular and metabolic diseases.

Hair loss is a type of skin disease, and the common types of hair loss are mainly divided into androgenic alopecia, alopecia areata, psychogenic alopecia, genetic alopecia, etc. 95% of the hair loss belongs to androgenic alopecia. Youngen continues to expand its research capabilities through advanced biotechnical solutions across multiple therapeutic areas.

Hair loss is a type of skin disease, and the common types of hair loss are mainly divided into androgenic alopecia, alopecia areata, psychogenic alopecia, genetic alopecia, etc. 95% of the hair loss belongs to androgenic alopecia. Through continued scientific innovation, Youngen aims to advance life therapeutic solutions for diseases with significant unmet medical needs.